112 related articles for article (PubMed ID: 17161515)
21. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
Fu Y; Li J; Lee AS
Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
[TBL] [Abstract][Full Text] [Related]
22. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
23. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.
Dong D; Ko B; Baumeister P; Swenson S; Costa F; Markland F; Stiles C; Patterson JB; Bates SE; Lee AS
Cancer Res; 2005 Jul; 65(13):5785-91. PubMed ID: 15994954
[TBL] [Abstract][Full Text] [Related]
24. T cell receptor-mediated signaling induces GRP78 expression in T cells: the implications in maintaining T cell viability.
Takano S; Ando T; Hiramatsu N; Kanayama A; Maekawa S; Ohnuma Y; Enomoto N; Ogawa H; Paton AW; Paton JC; Kitamura M; Nakao A
Biochem Biophys Res Commun; 2008 Jul; 371(4):762-6. PubMed ID: 18457657
[TBL] [Abstract][Full Text] [Related]
25. Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance.
Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Yoshimastu T; Morita M; Yasumoto K
Lung Cancer; 2005 Jul; 49(1):55-62. PubMed ID: 15949590
[TBL] [Abstract][Full Text] [Related]
26. Glucose regulated proteins 78 protects insulinoma cells (NIT-1) from death induced by streptozotocin, cytokines or cytotoxic T lymphocytes.
Wang M; Zhao XR; Wang P; Li L; Dai Y; Huang H; Lei P; Zhu HF; Shen GX
Int J Biochem Cell Biol; 2007; 39(11):2076-82. PubMed ID: 17689130
[TBL] [Abstract][Full Text] [Related]
27. Targeting the unfolded protein response in cancer therapy.
Backer MV; Backer JM; Chinnaiyan P
Methods Enzymol; 2011; 491():37-56. PubMed ID: 21329793
[TBL] [Abstract][Full Text] [Related]
28. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
29. New glycosylated derivatives of versipelostatin, the GRP78/Bip molecular chaperone down-regulator, from Streptomyces versipellis 4083-SVS6.
Zhao P; Ueda JY; Kozone I; Chijiwa S; Takagi M; Kudo F; Nishiyama M; Shin-ya K; Kuzuyama T
Org Biomol Chem; 2009 Apr; 7(7):1454-60. PubMed ID: 19300832
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin.
Cui H; Darmanin S; Natsuisaka M; Kondo T; Asaka M; Shindoh M; Higashino F; Hamuro J; Okada F; Kobayashi M; Nakagawa K; Koide H; Kobayashi M
Cancer Res; 2007 Apr; 67(7):3345-55. PubMed ID: 17409444
[TBL] [Abstract][Full Text] [Related]
31. VP-16 resistance in the NCI-H460 human lung cancer cell line is significantly associated with glucose-regulated protein78 (GRP78) induction.
Wang Q; Wang T; Wang Y; Wang W; Wang Y; Hu X; Shao S; Zhang J; Suo Z
Anticancer Res; 2007; 27(4B):2359-64. PubMed ID: 17695526
[TBL] [Abstract][Full Text] [Related]
32. Use of chemical genomics in assessment of the UPR.
Saito S; Tomida A
Methods Enzymol; 2011; 491():327-41. PubMed ID: 21329808
[TBL] [Abstract][Full Text] [Related]
33. GRP78 signaling hub a receptor for targeted tumor therapy.
Sato M; Yao VJ; Arap W; Pasqualini R
Adv Genet; 2010; 69():97-114. PubMed ID: 20807604
[TBL] [Abstract][Full Text] [Related]
34. GRP78 and Raf-1 cooperatively confer resistance to endoplasmic reticulum stress-induced apoptosis.
Shu CW; Sun FC; Cho JH; Lin CC; Liu PF; Chen PY; Chang MD; Fu HW; Lai YK
J Cell Physiol; 2008 Jun; 215(3):627-35. PubMed ID: 18064632
[TBL] [Abstract][Full Text] [Related]
35. GRP78 induction in cancer: therapeutic and prognostic implications.
Lee AS
Cancer Res; 2007 Apr; 67(8):3496-9. PubMed ID: 17440054
[TBL] [Abstract][Full Text] [Related]
36. Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand.
Kim Y; Lillo AM; Steiniger SC; Liu Y; Ballatore C; Anichini A; Mortarini R; Kaufmann GF; Zhou B; Felding-Habermann B; Janda KD
Biochemistry; 2006 Aug; 45(31):9434-44. PubMed ID: 16878978
[TBL] [Abstract][Full Text] [Related]
37. Relative and absolute configuration of versipelostatin, a down-regulator of molecular chaperone GRP78 expression.
Park HR; Chijiwa S; Furihata K; Hayakawa Y; Shin-Ya K
Org Lett; 2007 Apr; 9(8):1457-60. PubMed ID: 17352484
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of GRP78 and GRP94 and its function in chemotherapy resistance to VP-16 in human lung cancer cell line SK-MES-1.
Zhang L; Wang S; Wangtao ; Wang Y; Wang J; Jiang L; Li S; Hu X; Wang Q
Cancer Invest; 2009 May; 27(4):453-8. PubMed ID: 19212831
[TBL] [Abstract][Full Text] [Related]
39. Repositioning of Verrucosidin, a purported inhibitor of chaperone protein GRP78, as an inhibitor of mitochondrial electron transport chain complex I.
Thomas S; Sharma N; Gonzalez R; Pao PW; Hofman FM; Chen TC; Louie SG; Pirrung MC; Schönthal AH
PLoS One; 2013; 8(6):e65695. PubMed ID: 23755268
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis.
Jiang CC; Chen LH; Gillespie S; Wang YF; Kiejda KA; Zhang XD; Hersey P
Cancer Res; 2007 Oct; 67(20):9750-61. PubMed ID: 17942905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
